EBIT: Income before interest and taxes.
Heron Therapeutics, Inc. (HRTX) had EBIT of $-4.76M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$34.71M |
|
$-8.11M |
|
$10.64M |
|
$24.07M |
|
$39.48M |
|
$-4.76M |
|
$-3.35M |
|
$-8.11M |
|
$-8.11M |
|
$-8.11M |
|
$-8.11M |
|
$-8.11M |
|
$-8.11M |
|
|
EBIT |
$-4.76M |
$-4.16M |
|
189.65M |
|
189.65M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$228.98M |
|
$12.03M |
|
$17.23M |
|
$246.22M |
|
$90.52M |
|
$141.63M |
|
$146.56M |
|
$237.08M |
|
$8.09M |
|
$9.14M |
|
$9.14M |
|
188.58M |
|
| Cash Flow Statement Financials | |
$-1.54M |
|
$-0.94M |
|
$-0.05M |
|
$28.65M |
|
$26.12M |
|
$-2.53M |
|
$2.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.53 |
|
-- |
|
-- |
|
0.94 |
|
15.50 |
|
69.35% |
|
-13.73% |
|
-13.73% |
|
-- |
|
-23.37% |
|
-23.37% |
|
$-1.93M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.12 |
|
0.41 |
|
217.00 |
|
-100.30% |
|
-88.77% |
|
-3.29% |
|
-5.38% |
|
$0.05 |
|
$-0.01 |
|
$-0.01 |
|